<SEC-DOCUMENT>0001104659-26-003016-index.html : 20260112
<SEC-HEADER>0001104659-26-003016.hdr.sgml : 20260112
<ACCEPTANCE-DATETIME>20260112215806
ACCESSION NUMBER:		0001104659-26-003016
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20260108
FILED AS OF DATE:		20260112
DATE AS OF CHANGE:		20260112

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Tananbaum James B.
		CENTRAL INDEX KEY:			0001581754
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42143
		FILM NUMBER:		26528306

	MAIL ADDRESS:	
		STREET 1:		3052 PACIFIC AVENUE
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94115

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALUMIS INC.
		CENTRAL INDEX KEY:			0001847367
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		280 EAST GRAND AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650-231-6625

	MAIL ADDRESS:	
		STREET 1:		280 EAST GRAND AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ESKER THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20230427

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FL2021-001, Inc.
		DATE OF NAME CHANGE:	20210222
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>tm263003-1_4seq1.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
Document 1 - file: tm263003-1_4seq1.html

Document 1 - RAW XML: tm263003-1_4seq1.xml

</DOCUMENT>
</SEC-DOCUMENT>